Siveen et al. found that TQ enhances chemosensitization and anticancer activity of Bortezomib in human multiple myeloma cells and mouse xenografts via inhibition of the NF-κB pathway [48]. This evidence concerns the gene NFKB1 and AL amyloidosis.